Suppression of tumor growth and metastasis in Mgat5-deficient mice

Nature Medicine

Volumn 6, Issue 3, 2000, Pages 306-312

  Granovsky, Maria ^a,b   Fata, Jimmie ^c   Pawling, Judy ^a   Muller, William J ^d   Khokha, Rama ^c   Dennis, James W ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCAN DERIVATIVE; GLYCOPROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INHIBITION; EMBRYO; FEEDBACK SYSTEM; GENOTYPE; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ANIMALS; CARBOHYDRATE SEQUENCE; CARCINOMA; CROSSES, GENETIC; FEMALE; FIBROADENOMA; GOLGI APPARATUS; HUMANS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTAGENESIS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM METASTASIS; POLYSACCHARIDES; RECOMBINANT PROTEINS;

ANIMALIA; POLYOMAVIRUS;

EID: 0034061923     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/73163     Document Type: Article

References (41)

1. Yamashita, K., Ohkura, T., Tachibana, Y., Takasaki, S. & Kobata, A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J. Biol. Chem. 259, 10834-10840 (1984).
2. Pierce, M. & Arango, J. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri-and tetraantennary glycopeptides containing [GlcNAc-β(1,6)Man-α;(1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J. Biol. Chem. 261, 10772-10777 (1986).
3. Cummings, R.D., Trowbridge, I.S & Kornfeld, S. A mouse lymphoma cell line resistant to the leukoagglutinating lectin from Phaseolus vulgaris is deficient in UDP-GlcNAc:α-D-mannoside β1, 6 N-acetylglucosaminyltransferase. J. Biol. Chem. 257, 13421-13427 (1982).
4. Shoreibah, M. et al. Isolation, characterization, and expression of cDNA encoding N-Acetylglucosaminyltransferase V. J. Biol. Chem. 268, 15381-15385 (1993).
5. Cummings, R.D. & Kornfeld, S. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectin. J. Biol. Chem. 257, 11230-11234 (1982).
6. Fernandes, B., Sagman, U., Auger, M., Demetriou, M. & Dennis, J.W. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 51, 718-723 (1991).
7. Seelentag, W.K., et al. Prognostic value of β1, 6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 58, 5559-5564 (1998).
8. Yamashita, K., Tachibana, Y., Ohkura, T. & Kobata, A. Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J. Biol. Chem. 260, 3963-3969 (1985).
9. Dennis, J.W., Kosh, K., Bryce, D.-M. & Breitman, M.L. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene 4, 853-860 (1989).
10. Dennis, J.W., Laferte, S., Waghorne, C., Breitman, M.L. & Kerbel, R.S. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236, 582-585 (1987).
11. Kang, R. et al. Transcriptional regulation of the N-acetylglucosaminyltranserase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. J. Biol.Chem. 271, 26706-26712 (1996).
12. Chen, L., Zhang, W., Fregien, N. & Pierce, M. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 17, 2087-2093 (1998).
13. Lu, Y., Pelling, J.C. & Chaney, W.G. Tumor cells surface β1-6 branched oligosaccharides and lung metastasis. Clin. Exp. Metastasis 12, 47-54 (1994).
14. Demetriou, M., Nabi, I.R., Coppolino, M., Dedhar, S. & Dennis, J.W. Reduced contact inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 130, 383-392 (1995).
15. Seberger, P.J. & Chaney, W.G. Control of metastasis by asn-linked, β1-6 branched oligosaccharides in mouse mammary cancer cells. Glycobiology 9, 235-241 (1999).
16. Do, K.-Y., Fregien, N., Pierce, M. & Cummings, R.D. Modification of glycoproteins by N-acetylglucosaminyltransferase V is greatly influenced by accessibility of the enzyme to oligosacharide acceptors. J. Biol. Chem 269, 23456-23464 (1994).
17. Nakagawa, H., et al. Detailed oligosaccharide structures of human integrin alpha 5 beta 1 analyzed by a three-dimensional mapping technique. Eur. J. Biochem. 237, 76-85 (1996).
18. Asada, M., Furukawa, K., Kantor, C., Gahmberg, C.G. & Kobata, A. Structural study of the sugar chains of human leukocyte cell adhesion molecules CD11/CD18. Biochemistry 30, 1561-1571 (1991).
19. Skelton, T.P., Zeng, C., Nocks, A. & Stamenkovic, I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 140, 431-446 (1998).
20. Diamond, M.S., Staunton, D.E., Martin, S.D. & Springer, T.A. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54)and its regulation by glycosylation. Cell 65, 961-971 (1991).
21. McEvoy, L.M., Sun, H., Frelinger, J.G. & Butcher, E.C. Anti-CD43 inhibition of T cell homing. J. Exp. Med. 185, 1493-1498 (1997).
22. Verbeek, B.S. et al. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J. Pathol. 180, 383-388 (1996)
23. Liu, A.X., et al. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, andv-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res. 58, 2973-2977 (1998).
24. Dilworth, S.M. et al. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature 367, 87-90 (1994).
25. Whitman, M., Kaplan, D.R., Schaffhausen, B., Cantley, L. & Roberts, T.M. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315, 239-242 (1985).
26. Guy, C.T., Muthuswamy, S.K., Cardiff, R.D., Soriano, P. & Muller, W.J. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 1, 23-32 (1994).
27. Webster, M.A. et alRequirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18, 2344-2359 (1998).
28. Guy, C.T., Cardiff, R.D. & Muller, W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954-961 (1992).
29. Bronson, R., Dawe, C., Carroll, J. & Benjamin, T. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc. Natl. Acad. Sci. USA 94, 7954-7958 (1997).
30. Granovsky, M. et al. GlcNAc-transferase V and core 2 GlcNAc-transferase expression in the developing mouse embryo. Glycobiology 5, 797-806 (1995).
31. Turner, C.E. Molecules in focus, paxillin. Int. J. Biol. Macromol. 30, 955-959 (1998).
32. Reif, K., Nobes, C.D., Thomas, G., Hall, A. & Cantrell, D.A. phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho dependent effector pathways. Curr. Biol. 6, 1445-1455 (1996).
33. Spector, I., Shochet, N.R., Blasberger, D. & Kashman, Y. Latrunculins, novel marine macroltdes that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. Cell Motil. Cytoskeleton 13, 127-124 (1989).
34. Cheng, A.M. et al. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95, 793-803 (1999).
35. Neznanov, N. et al. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. Cancer Res. 59, 4242-4246 (1999).
36. Keely, P.J., Westwick, J.K., Whitehead, J.P., Der, C.J. & Parise, L.V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390, 632-636 (1997).
37. King, W.G., Mattaliano, M.D., Chan T.O., Tsichlis, P.N. & Brugge, J.S. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Biol. Cell 17, 4406-4418 (1997).
38. Humphries, M.J., Matsumoto, K., White, S.L. & Olden, K. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc. Natl. Acad. Sci. USA 83, 1752-1756 (1986).
39. Dennis, J.W. Effects of swainsonine and polyinosinic-polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res. 46, 5131-5136 (1986).
40. Goss, P.E., Baptiste, J., Fernandes, B., Baker, M. & Dennis, J.W. A study of swainsonine in patients with advanced malignancies. Cancer Res. 54, 1450-1457 (1994).
41. Hasty, P. & Bradley, A. in Gene Targeting. A Practical Approach (ed. Joyner, A.) 138-180 (IRL Oxford Press, 1993).